Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 3 X-linked (DDX3X) is a multifunctional ATP-dependent RNA helicase belonging to the DEAD-box protein family [4, 9]. It plays a central role in nearly all aspects of RNA metabolism, including transcription, pre-mRNA splicing, mRNA export, and translation initiation, particularly for mRNAs with complex 5' untranslated regions [11, 12]. Beyond its core RNA-processing functions, DDX3X is a key regulator of cellular signaling pathways such as Wnt/beta-catenin and NF-kappaB, and it is involved in the formation of stress granules and the innate immune response [5, 10, 18]. In oncology, DDX3X is frequently overexpressed and acts as an oncogene in various cancers, including breast, colorectal, and glioblastoma, where it promotes cell proliferation and metastasis [1, 13, 15]. Conversely, it can act as a tumor suppressor in certain contexts, such as in some cases of hepatocellular carcinoma [25, 27]. DDX3X is also a critical host factor for the replication of numerous viruses, including HIV-1, HCV, and SARS-CoV-2, making it a promising target for broad-spectrum antiviral therapy [6, 10, 29]. Small molecule inhibitors like RK-33 and BA103 are being developed to target its ATPase or helicase activities to treat cancer and viral infections [1, 31].
Inhibition of the ATP-binding site (ATPase activity) or the RNA-binding site (helicase activity), leading to suppressed mRNA translation of oncogenic proteins, disruption of Wnt/beta-catenin signaling, and induction of the innate immune response [1, 13, 15, 30].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 3 X-linked (DDX3X) (DDX3X).